Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Demand Outlook for GLP-1 Nutritional Support Market in the United States The CAGR of the GLP-1 nutritional support market in the United States rose from approximately 8.2% during 2020 to 2024 to 11.2% for 2025 to 2035, supported by stronger insurance reimbursement frameworks and physician adoption across outpatient metabolic care
3, 2023, pp
Mounj@ro powered by Tirzepatide, a dual-action GLP-1 + GIP receptor agonist
Semaglutide the active ingredient in Ozempic and Wegovy activates receptors for glucagon-like peptide-1 (GLP-1), a gut hormone that reduces appetite and promotes fullness by slowing the rate at which food leaves the stomach
Gradual increases let your body adapt incrementally
A Cardiorenal Medicine study found obesity significantly increases the risk of cardiovascular disease, type 2 diabetes, certain cancers, and fatty liver disease
US$ 27.36
US$ 20.56
US$ 24.17
US$ 29.64
